Severe epidermal necrolysis after bortezomib treatment for multiple myeloma

Acta Haematol. 2007;118(2):65-7. doi: 10.1159/000102604. Epub 2007 May 15.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Dexamethasone / therapeutic use
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Pyrazines / adverse effects*
  • Stevens-Johnson Syndrome / drug therapy
  • Stevens-Johnson Syndrome / etiology*
  • Vasculitis, Leukocytoclastic, Cutaneous / chemically induced
  • Vasculitis, Leukocytoclastic, Cutaneous / drug therapy

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Immunosuppressive Agents
  • Pyrazines
  • Bortezomib
  • Dexamethasone